Hamps Bio Limited (BOM:544312)
India · Delayed Price · Currency is INR 25.50
-0.40 (-1.54%)
At close: Sep 7, 2026
Hamps Bio Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 84.75 | 66.69 | 64.75 | 55.78 | 53.41 |
Other Revenue | - | - | - | - | -0 |
| 84.75 | 66.69 | 64.75 | 55.78 | 53.4 | |
Revenue Growth | 27.08% | 2.99% | 16.08% | 4.45% | 39.71% |
Cost of Revenue | 33.35 | 21.27 | 18.1 | 19.05 | 22.71 |
Gross Profit | 51.4 | 45.41 | 46.66 | 36.73 | 30.69 |
Selling, General & Admin | 27.27 | 23.84 | 21.22 | 18.06 | 16.99 |
Other Operating Expenses | 21.07 | 13.68 | 13.52 | 10.01 | 7.55 |
Operating Expenses | 56.5 | 41.29 | 38.77 | 31.46 | 27.79 |
Operating Income | -5.11 | 4.13 | 7.88 | 5.28 | 2.9 |
Interest Expense | -2.32 | -1.11 | -1.43 | -1.71 | -1.87 |
Interest & Investment Income | 0.37 | 1.27 | 0.07 | 0.03 | 0.03 |
Currency Exchange Gain (Loss) | 0.23 | 0.04 | - | - | - |
Other Non Operating Income (Expenses) | -0.17 | -0.29 | -0.02 | -0.07 | -0.03 |
EBT Excluding Unusual Items | -7 | 4.04 | 6.5 | 3.53 | 1.04 |
Gain (Loss) on Sale of Investments | - | - | - | 0.01 | - |
Other Unusual Items | - | - | - | 0.03 | 0.01 |
Pretax Income | -7 | 4.04 | 6.5 | 3.57 | 1.05 |
Income Tax Expense | 0.39 | 1.06 | 1.49 | -0.02 | -0.17 |
Net Income | -7.39 | 2.98 | 5.01 | 3.59 | 1.22 |
Net Income to Common | -7.39 | 2.98 | 5.01 | 3.59 | 1.22 |
Net Income Growth | - | -40.53% | 39.44% | 195.47% | - |
Shares Outstanding (Basic) | 9 | 9 | 4 | 5 | 5 |
Shares Outstanding (Diluted) | 9 | 9 | 4 | 5 | 5 |
Shares Change | - | 122.25% | -26.76% | - | 11.50% |
EPS (Basic) | -0.85 | 0.34 | 1.28 | 0.67 | 0.23 |
EPS (Diluted) | -0.85 | 0.34 | 1.27 | 0.67 | 0.23 |
EPS Growth | - | -73.33% | 90.30% | 197.78% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -58.46 | -54.8 | -6.54 | 4 | 0.42 |
Free Cash Flow Per Share | -6.71 | -6.29 | -1.67 | 0.75 | 0.08 |
Gross Margin | 60.65% | 68.10% | 72.05% | 65.85% | 57.48% |
Operating Margin | -6.03% | 6.19% | 12.17% | 9.46% | 5.43% |
Profit Margin | -8.72% | 4.46% | 7.73% | 6.44% | 2.27% |
Free Cash Flow Margin | -68.98% | -82.17% | -10.09% | 7.18% | 0.78% |
EBITDA | 2.93 | 7.89 | 11.92 | 8.66 | 6.15 |
EBITDA Margin | 3.46% | 11.83% | 18.41% | 15.53% | 11.52% |
D&A For EBITDA | 8.04 | 3.76 | 4.04 | 3.39 | 3.25 |
EBIT | -5.11 | 4.13 | 7.88 | 5.28 | 2.9 |
EBIT Margin | -6.03% | 6.19% | 12.17% | 9.46% | 5.43% |
Effective Tax Rate | - | 26.27% | 22.97% | - | - |
Revenue as Reported | 88.07 | 68.2 | 65.01 | 55.85 | 53.45 |
Advertising Expenses | 0.86 | 0.57 | 0.66 | - | - |